Association of peripheral blood CD4+T-cell depletion under temozolomide with inferior survival of patients with IDH wildtype glioblastoma.

被引：0
|
作者：
Weller, Michael
Terksikh, Ekaterina
Silginer, Manuela
Krieg, Carsten
Roth, Patrick
Becher, Burkhard
Wirsching, Hans-Georg
机构：
[1] Dept Neurol, Lab Mol Neurooncol, Zurich, Switzerland
[2] Univ Hosp, Neurosci Ctr Zurich, Zurich, Switzerland
[3] Univ Zurich, Zurich, Switzerland
[4] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland
[5] Univ Hosp, Zurich, Switzerland
[6] Univ Zurich, Clin Neurosci Ctr, Zurich, Switzerland
[7] Dept Neurol, Zurich, Switzerland
[8] Med Univ South Carolina, Charleston, SC USA
[9] Univ Hosp Zurich, Zurich, Switzerland
[10] Univ Hosp, Dept Neurol, Zurich, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2548
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The regulatory/activated CD4+T-cell ratio in peripheral blood predict response to fingolimod in multiple sclerosis patients
    Villar Guimerans, L. M.
    Picon, C.
    Sainz de la Maza, S.
    Rodriguez-Martin, E.
    Espino, M.
    Bermejo, A.
    de Andres, C.
    Aladro, Y.
    Alvarez-Cermeno, J. C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 593 - 593
  • [2] Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma
    He, Lu
    Liang, Jin-Hua
    Wu, Jia-Zhu
    Li, Yue
    Qin, Shu-Chao
    Miao, Yi
    Wu, Yu-Jie
    Wang, Yan
    Wang, Li
    Fan, Lei
    Li, Jian-Yong
    Xu, Wei
    TUMOR BIOLOGY, 2016, 37 (09) : 12589 - 12595
  • [3] PERIPHERAL BLOOD CD4+MONONUCLEAR CELL FRACTIONS ARE ASSOCIATED WITH OVERALL SURVIVAL AT FIRST RECURRENCE OF IDH-WILDTYPE GLIOBLASTOMA AFTER STANDARD CHEMORADIOTHERAPY: SECONDARY ANALYSES OF THE PHASE II DIRECTOR TRIAL
    Wirsching, Hans-Georg
    Terksikh, Ekaterina
    Silginer, Manuela
    Krieg, Carsten
    Tabatabai, Ghazaleh
    Wick, Wolfgang
    Reifenberger, Guido
    Roth, Patrick
    Becher, Burkhard
    Weller, Michael
    NEURO-ONCOLOGY, 2018, 20 : 14 - 14
  • [4] Repeated CD4+T-Cell Depletion in Patients with Rheumatoid Arthritis over Multiple Cycles of Rituximab Treatment
    Lavielle, Matthieu
    Mulleman, Denis
    Sung, Hsueh Cheng
    Bahuaud, Clement
    Goupille, Philippe
    Watier, Herve
    Thibault, Gilles
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] Features of the CD4+T-cell response in liver and peripheral blood of HCV patients with persistently normal and altered alt levels.
    Rico, MA
    Quiroga, JA
    Subira, D
    Garcia, E
    Castanon, S
    Manzano, H
    Pardo, M
    Carreno, V
    HEPATOLOGY, 2000, 32 (04) : 264A - 264A
  • [6] Infliximab Reverses Peripheral CD4+T Cell Depletion in Lymphopenic Sarcoidosis Patients
    Crouser, E. D.
    Julian, M. W.
    Shao, G.
    Fox, C.
    Hauswirth, D.
    Jehn, J.
    Lozanski, G.
    Erdal, S.
    Wewers, M. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [7] Absolute peripheral CD4+T-cell count predicts prognosis of patients with diffuse large B-cell lymphoma
    Kusano, Yoshiharu
    Terui, Yasuhito
    CANCER SCIENCE, 2018, 109 : 493 - 493
  • [8] Low absolute CD4+ T cell counts in peripheral blood: an independent predictor of inferior survival in natural killer/T-cell lymphoma-a retrospective cohort study
    Zeng, Ruifang
    Zhu, Wenzhuo
    Jiang, Li
    Zhu, Xi
    Gao, Yan
    Xia, Yi
    Bai, Bing
    Shikama, Naoto
    Janetos, Timothy M.
    Dalia, Samir
    Alpdogan, Onder
    Wang, Xiaoxiao
    Zhu, Lingling
    Li, Pengfei
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (20)
  • [9] Possible Association of CD3+CD4-CD8-Phenotype of T-Cell Lymphoma with Peripheral Blood Eosinophilia
    Tabata, Rie
    Tabata, Chiharu
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024,
  • [10] Low absolute peripheral blood CD4+T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma
    Kusano, Y.
    Yokoyama, M.
    Terui, Y.
    Nishimura, N.
    Mishima, Y.
    Ueda, K.
    Tsuyama, N.
    Hirofumi, Y.
    Takahashi, A.
    Inoue, N.
    Takeuchi, K.
    Hatake, K.
    BLOOD CANCER JOURNAL, 2017, 7 : e558 - e558
12345